The DOI matches its Crossref record; 158 of the 159 references it cites were found in a registry or an index.
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Abstract
Tissue hypoxia results from an inadequate supply of oxygen (O(2)) that compromises biologic functions. Evidence from experimental and clinical studies increasingly points to a fundamental role for hypoxia in solid tumors. Hypoxia in tumors is primarily a pathophysiologic consequence of structurally and functionally disturbed microcirculation and the deterioration of diffusion conditions. Tumor hypoxia appears to be strongly associated with tumor propagation, malignant progression, and resistance to therapy, and it has thus become a central issue in tumor physiology and cancer treatment. Biochemists and clinicians (as well as physiologists) define hypoxia differently; biochemists define it as O(2)-limited electron transport, and physiologists and clinicians define it as a state of reduced O(2) availability or decreased O(2) partial pressure that restricts or even abolishes functions of organs, tissues, or cells. Because malignant tumors no longer execute functions necessary for homeostasis (such as the production of adequate amounts of adenosine triphosphate), the physiology-based definitions of the term "hypoxia" are not necessarily valid for malignant tumors. Instead, alternative definitions based on clinical, biologic, and molecular effects that are observed at O(2) partial pressures below a critical level have to be applied.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wang, G. L., Jiang, B. H., Rue, E. A., & Semenza, G. L. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.12.5510 · Cited by 6,212
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Radiobiology for the Radiologist.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-3-438_1 · Cited by 3,498
(1989) · PubMed · Cited by 3,343
Self-citationHypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
Graeber, T. G., Osmanian, C., Jacks, T., Housman, D. E., Koch, C. J., Lowe, S. W., & Giaccia, A. J. (1996) · Nature · doi:10.1038/379088a0 · Cited by 2,300
Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., & Scott, O. C. A. (1953) · The British Journal of Radiology · doi:10.1259/0007-1285-26-312-638 · Cited by 2,158
Holmgren, L., O’Reilly, M. S., & Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0295-149 · Cited by 1,891
HIF-1: mediator of physiological and pathophysiological responses to hypoxia
Semenza, G. L. (2000) · Journal of Applied Physiology · doi:10.1152/jappl.2000.88.4.1474 · Cited by 1,822
Höckel, M., Schlenger, K., Aral, B., Mitze, M., Schäffer, U., & Vaupel, P. W. (1996) · PubMed · Cited by 1,727
Self-citation
Research works printed but not linked: 35
- Brown, 1998, Cancer Research, 58, 1408
- Hockel, 1996, Cancer Research, 56, 4509
- Brizel, 1996, Cancer Research, 56, 941
- Walenta, 2000, Cancer Research, 60, 916
- Hockel, 1999, Cancer Research, 59, 4525
- Kim, 1997, Cancer Research, 57, 4200
- Anthoney, 1996, Cancer Research, 56, 1374
- Vaupel, 1989, Cancer Research, 49, 6449
- Vaupel, 1987, Cancer Research, 47, 3496
- Kallinowski, 1989, Cancer Research, 49, 3759
- 1973, Advances in experimental medicine and biology, 37, 277
- Vaupel, 1991, Cancer Research, 51, 3316
- Hockel, 1991, Cancer Research, 51, 6098
- Wilson, 1992, Cancer Research, 52, 3988
- 1996, BRITISH JOURNAL OF CANCER, 74, S226
- Valk, 1992, Journal of Nuclear Medicine, 33, 2133
- Groshar, 1993, Journal of Nuclear Medicine, 34, 885
- Lord, 1993, Cancer Research, 53, 5721
- Evans, 1996, Cancer Research, 56, 405
- Riva, 1998, Anticancer Research, 18, 4729
- Prehn, 1991, Cancer Research, 51, 2
- Ausserer, 1994, Molecular and Cellular Biology, 14, 5032, 10.1128/mcb.14.8.5032 · DOI
- Hartmann, 1999, Cancer Research, 59, 1578
- Koong, 1994, Cancer Research, 54, 1425
- Henderson, 1987, Cancer Research, 47, 3110
- Mitchell, 1985, Cancer Research, 45, 2008
- Reynolds, 1996, Cancer Research, 56, 5754
- Stoler, 1992, Cancer Research, 52, 4372
- Russo, 1995, Cancer Research, 55, 1122
- Teicher, 1990, Cancer Research, 50, 3339
- Teicher, 1981, Cancer Research, 41, 73
- Moan, 1985, Cancer Research, 45, 1608
- 1981, Bibliotheca anatomica, 20, 628
- 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 46, S107
- 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 48, S162
Cited by
Sorted by citations
Items 601–700 of 1,008
Novel clinical therapeutics targeting the epithelial to mesenchymal transition
Kothari, A. N., Mi, Z., Zapf, M. A. C., & Kuo, P. C. (2014) · Clinical and Translational Medicine · doi:10.1186/s40169-014-0035-0 · Cited by 74
Kulkarni, P., Haldar, M. K., Katti, P. D., Dawes, C., You, S., Choi, Y., & Mallik, S. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00241 · Cited by 77
Carboxymethyl dextran-based hypoxia-responsive nanoparticles for doxorubicin delivery
Son, S., Rao, N. V., Ko, H., Shin, S., Jeon, J., Han, H. S., Nguyen, V. Q., Thambi, T., Suh, Y. D., & Park, J. H. (2017) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2017.11.048 · Cited by 74
Büchler, P., Reber, H. A., Tomlinson, J. S., Hankinson, O., Kallifatidis, G., Frieß, H., Herr, I., & Hines, O. J. (2009) · Neoplasia · doi:10.1593/neo.08734 · Cited by 75
Ascorbate depletion mediates up‐regulation of hypoxia‐associated proteins by cell density and nickel
Karaczyn, A. A., Ivanov, S. V., Reynolds, M., Zhitkovich, A., Kasprzak, K. S., & Salnikow, K. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20705 · Cited by 77
Seo, B. R., DelNero, P. F., & Fischbach, C. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.11.011 · Cited by 75
Normal to cancer microbiome transformation and its implication in cancer diagnosis
Khan, A. A., Shrivastava, A., & Khurshid, M. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.05.005 · Cited by 75
Palma, S. D., Ripamonti, M., Viganò, A., Moriggi, M., Capitanio, D., Samaja, M., Milano, G., Cerretelli, P., Wait, R., & Gelfi, C. (2007) · Journal of Proteome Research · doi:10.1021/pr060614o · Cited by 76
McPhail, L. D., & Robinson, S. P. (2009) · Radiology · doi:10.1148/radiol.2541090395 · Cited by 74
Natsuizaka, M., Ozasa, M., Darmanin, S., Miyamoto, M., Kondo, S., Kamada, S., Shindoh, M., Higashino, F., Suhara, W., Koide, H., et al. (2007) · Experimental Cell Research · doi:10.1016/j.yexcr.2007.06.013 · Cited by 74
Autophagy contributes to the chemo-resistance of non-small cell lung cancer in hypoxic conditions
Lee, J. G., Shin, J. H., Shim, H. S., Lee, C. Y., Kim, D. J., Kim, Y. S., & Chung, K. S. (2015) · Respiratory Research · doi:10.1186/s12931-015-0285-4 · Cited by 75
Hoogsteen, I. J., Marres, H. A. M., Wijffels, K. I. E. M., Rijken, P. F. J. W., Peters, J. P. W., van den Hoogen, F. J. A., Oosterwijk, E., van der Kogel, A. J., & Kaanders, J. H. A. M. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.97.11.1 · Cited by 74
Mendichovszky, I. A., & Jackson, A. (2011) · British Journal of Radiology · doi:10.1259/bjr/82292521 · Cited by 74
Bonnitcha, P., Vāvere, A. L., Lewis, J. S., et al. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm800031x · Cited by 74
Blood pressure control and diabetic retinopathy
Klein, R. (2002) · British Journal of Ophthalmology · doi:10.1136/bjo.86.4.365 · Cited by 74
Metabolic microenvironment of tumor cells: a key factor in malignant progression.
Vaupel, P. W. (2010) · PubMed · Cited by 73
Self-citationCapsaicin inhibits benzo(a)pyrene-induced lung carcinogenesis in an in vivo mouse model
Anandakumar, P., Kamaraj, S., Jagan, S., et al. (2012) · Inflammation Research · doi:10.1007/s00011-012-0511-1 · Cited by 73
Sun, C., Yuan, J., Koh, W., Lee, H.-P., & Yu, M. C. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm171 · Cited by 73
Huang, W.-C., Chen, S., Chiang, W., Huang, C.-W., Lo, C.-L., Chern, C., & Chiu, H. (2016) · Biomacromolecules · doi:10.1021/acs.biomac.6b00956 · Cited by 74
Hypoxic Microenvironment and Metastatic Bone Disease
Hiraga, T. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113523 · Cited by 78
Calvani, M., Trisciuoglio, D., Bergamaschi, C., Shoemaker, R. H., & Melillo, G. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5564 · Cited by 80
Role of hydrogen sulphide in physiological and pathological angiogenesis
Zhang, Y., Jing, M., Cai, C., Zhu, S., Zhang, C.-J., Wang, Q., Zhai, Y., Ji, X., & Wu, D. (2022) · Cell Proliferation · doi:10.1111/cpr.13374 · Cited by 73
Regulation of G1 Arrest and Apoptosis in Hypoxia by PERK and GCN2-Mediated eIF2α Phosphorylation
Liu, Y., László, C., Liu, Y., Liu, W., Chen, X., Evans, S. C., & Wu, S. (2010) · Neoplasia · doi:10.1593/neo.91354 · Cited by 74
Amini, M. A., Abbasi, A. Z., Cai, P., Lip, H., Gordijo, C. R., Li, J., Chen, B., Zhang, L., Rauth, A. M., & Wu, X. Y. (2018) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djy131 · Cited by 72
Bai, S., Ma, X., Shi, X., Shao, J., Zhang, T., Wang, Y., Cheng, Y., Xue, P., Kang, Y., & Xu, Z. (2019) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.9b13214 · Cited by 75
HIF-transcribed p53 chaperones HIF-1α
Madan, E., Parker, T. M., Pelham, C. J., Palma, A. M., Peixoto, M. L., Nagane, M., Chandaria, A., Tomás, A. R., Canas‐Marques, R., Henriques, V., et al. (2019) · Nucleic Acids Research · doi:10.1093/nar/gkz766 · Cited by 74
Wei, T.-T., Lin, Y., Tang, S.-P., Luo, C.-K., Tsai, C.-C., Shun, C., & Chen, C. (2019) · Oncogene · doi:10.1038/s41388-019-0999-8 · Cited by 73
Metastasis and stem cell pathways
Barnhart, B. C., & Simon, M. C. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-007-9053-3 · Cited by 74
Winum, J., Vullo, D., Casini, A., et al. (2003) · Journal of Medicinal Chemistry · doi:10.1021/jm030911u · Cited by 71
Advances in the targeting of HIF-1α and future therapeutic strategies for glioblastoma multiforme
Wang, G., Wang, J., Fu, X., Guang, R., & To, S.-S. T. (2016) · Oncology Reports · doi:10.3892/or.2016.5309 · Cited by 71
Mboge, M. Y., Mahon, B. P., Lamas, N., et al. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.03.026 · Cited by 71
Ascorbate Depletion: A Critical Step in Nickel Carcinogenesis?
Salnikow, K., & Kasprzak, K. S. (2005) · Environmental Health Perspectives · doi:10.1289/ehp.7605 · Cited by 72
Ogden, A., Rida, P. C. G., & Aneja, R. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9413-5 · Cited by 70
Bollineni, V. R., Koole, M. J. B., Pruim, J., Brouwer, C. L., Wiegman, E. M., Groen, H. J. M., Vlasman, R., Halmos, G. B., Oosting, S. F., Langendijk, J. A., et al. (2014) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2014.10.010 · Cited by 70
Zhang, Y., Fu, J. F., Zhang, Z.-J., Ge, C.-C., & Yi, Y. (2016) · PubMed Central · Cited by 70
A microsystem for sensing and patterning oxidative microgradients during cell culture
Park, J., Bansal, T., Pinelis, M., & Maharbiz, M. M. (2006) · Lab on a Chip · doi:10.1039/b516483d · Cited by 69
Fokas, E., McKenna, W. G., & Muschel, R. J. (2012) · Cancer and Metastasis Reviews · doi:10.1007/s10555-012-9394-4 · Cited by 70
Veschini, L., Belloni, D., Foglieni, C., Cangi, M. G., Ferrarini, M., Caligaris‐Cappio, F., & Ferrero, E. (2006) · Blood · doi:10.1182/blood-2006-06-032664 · Cited by 71
Troost, E. G. C., Laverman, P., Kaanders, J. H. A. M., Philippens, M. E. P., Lok, J., Oyen, W. J. G., van der Kogel, A. J., Boerman, O. C., & Bussink, J. (2006) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2006.07.023 · Cited by 70
Hypoxia Suppression of Bim and Bmf Blocks Anoikis and Luminal Clearing during Mammary Morphogenesis
Whelan, K. A., Caldwell, S. A., Shahriari, K. S., Jackson, S. R., Franchetti, L. D., Johannes, G. J., & Reginato, M. J. (2010) · Molecular Biology of the Cell · doi:10.1091/mbc.e10-04-0353 · Cited by 71
Induction of dormancy in hypoxic human papillomavirus-positive cancer cells
Hoppe‐Seyler, K., Bossler, F., Lohrey, C., Bulkescher, J., Rösl, F., Jansen, L., Mayer, A., Vaupel, P. W., Dürst, M., & Hoppe‐Seyler, F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1615758114 · Cited by 72
Self-citationThe long noncoding RNA HIF1A‐AS2 facilitates cisplatin resistance in bladder cancer
Chen, X., Liu, M., Meng, F., Sun, B., Jin, X., & Jia, C. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.27327 · Cited by 69
Göschl, S., Schreiber‐Brynzak, E., Pichler, V., Cseh, K., Heffeter, P., Jungwirth, U., Jakupec, M. A., Berger, W., & Keppler, B. K. (2017) · Metallomics · doi:10.1039/c6mt00226a · Cited by 70
Mucin 1 Oncoprotein Blocks Hypoxia-inducible Factor 1α Activation in a Survival Response to Hypoxia
Li, Y., Kharbanda, S. M., & Kufe, D. W. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m610156200 · Cited by 70
Ye, L., Zhang, Q., Bai, X., Prasoon, P., Hu, Q., & Liang, T. (2014) · Pancreatology · doi:10.1016/j.pan.2014.06.008 · Cited by 72
Xu, R. X., Huang, J., Xu, J. S., Sun, D., Hinkle, G. H., Martin, E. W., & Povoski, S. P. (2009) · Journal of Biomedical Optics · doi:10.1117/1.3147424 · Cited by 69
Microenvironments and Cellular Characteristics in the Micro Tumor Cords of Malignant Solid Tumors
Yeom, C. J., Gotö, Y., Zhu, Y., Hiraoka, M., & Harada, H. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms131113949 · Cited by 70
Mimata, H., Nomura, T., Sato, F., & Yamasaki, M. (2007) · Oncology Reports · doi:10.3892/or.18.5.1145 · Cited by 69
Law, P. C., Au-Yeung, K. K. W., Chan, L.-Y., & Ko, J. K.-S. (2012) · BMC Complementary and Alternative Medicine · doi:10.1186/1472-6882-12-160 · Cited by 69
Chen, W.-L., Wang, C.-C., Lin, Y., Wu, C., & Hsieh, C. (2015) · Journal of Translational Medicine · doi:10.1186/s12967-015-0758-8 · Cited by 72
Bacon, A., Fox, S. B., Turley, H., & Harris, A. L. (2006) · Oncogene · doi:10.1038/sj.onc.1209761 · Cited by 73
Manka, D. R., Spicer, Z., & Millhorn, D. E. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-3091 · Cited by 71
Shida, M., Kitajima, Y., Nakamura, J., Yanagihara, K., BABA, K., Wakiyama, K., & Noshirο, H. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3359 · Cited by 70
Targeting Hypoxia-Driven Metabolic Reprogramming to Constrain Tumor Progression and Metastasis
Galvis, M. M., & Teng, Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155487 · Cited by 73
Vaupel, P. W., Flood, A. B., & Swartz, H. M. (2021) · Applied Magnetic Resonance · doi:10.1007/s00723-021-01383-6 · Cited by 75
Self-citationSun, X., Li, X.-F., Russell, J., Xing, L., Urano, M., Li, G. C., Humm, J. L., & Ling, C. C. (2008) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2008.05.015 · Cited by 68
Yi, X., Hur, H., Ham, I., Yun, J., Lee, J.-Y., Shim, W., Kim, Y. B., Lee, G., Han, S., & Cho, Y. K. (2013) · Experimental Cell Research · doi:10.1016/j.yexcr.2013.12.009 · Cited by 68
Breast tumor and stromal cell responses to TGF-β and hypoxia in matrix deposition
Curran, C. S., & Keely, P. J. (2012) · Matrix Biology · doi:10.1016/j.matbio.2012.11.016 · Cited by 71
Tumor physiologic response to combretastatin A4 phosphate assessed by MRI
Zhao, D., Jiang, L., Hahn, E. W., & Mason, R. P. (2005) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2005.03.009 · Cited by 68
Mayer, A., Höckel, M., & Vaupel, P. W. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-0869 · Cited by 71
Self-citationHu, J., Valckenborgh, E. V., Menu, E., Bruyne, E. D., & Vanderkerken, K. (2012) · Disease Models & Mechanisms · doi:10.1242/dmm.008961 · Cited by 69
Recent Progress in the Design of Hypoxia‐Specific Nano Drug Delivery Systems for Cancer Therapy
Sahu, A., Choi, W. I., & Tae, G. (2018) · Advanced Therapeutics · doi:10.1002/adtp.201800026 · Cited by 71
Mechanisms and significance of bifunctional NK4 in cancer treatment
Matsumoto, K., & Nakamura, T. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.131 · Cited by 68
Metabolism of Selenium, Selenocysteine, and Selenoproteins in Ferroptosis in Solid Tumor Cancers
Shimada, B. K., Swanson, S. M., Toh, P., & Seale, L. A. (2022) · Biomolecules · doi:10.3390/biom12111581 · Cited by 67
Targeting the lactic acid metabolic pathway for antitumor therapy
Li, Z., & Cui, J. (2023) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2023.100740 · Cited by 72
Robbins, J. R., Lee, S. M., Filipovich, A. H., Szigligeti, P., Neumeier, L., Petrovic, M., & Conforti, L. (2005) · The Journal of Physiology · doi:10.1113/jphysiol.2004.081893 · Cited by 67
Nutrient sensing, signal transduction and immune responses
Walls, J. F., Sinclair, L. V., & Finlay, D. K. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.09.001 · Cited by 69
Emmenegger, U., Morton, G., Francia, G., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2598 · Cited by 67
Cell-Based Drug Delivery Systems with Innate Homing Capability as a Novel Nanocarrier Platform
Choi, A., Javius-Jones, K., Hong, S., & Park, H. (2023) · International Journal of Nanomedicine · doi:10.2147/ijn.s394389 · Cited by 67
Tumor hypoxia unveiled: insights into microenvironment, detection tools and emerging therapies
Ciepła, J., & Smolarczyk, R. (2024) · Clinical and Experimental Medicine · doi:10.1007/s10238-024-01501-1 · Cited by 81
Challenges of PK/PD measurements in modern drug development
Workman, P. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00395-7 · Cited by 66
Hypoxia-inducible factor-1α correlates with MET and metastasis in node-negative breast cancer
Chen, H. H. W., Su, W., Lin, P. W., Guo, H., & Lee, W. (2006) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9360-3 · Cited by 66
Enamine N -Oxides: Synthesis and Application to Hypoxia-Responsive Prodrugs and Imaging Agents
Kang, D., Cheung, S. T., Wong-Rolle, A., & Kim, J. (2021) · ACS Central Science · doi:10.1021/acscentsci.0c01586 · Cited by 66
Zhang, Z.-Y., An, Y.-L., Wang, X.-S., Cui, L., Li, S., Liu, C., Zou, Y.-H., Zhang, F., & Zeng, R. (2022) · Bioactive Materials · doi:10.1016/j.bioactmat.2022.01.050 · Cited by 68
Takeuchi, S., Wang, W., Li, Q., Yamada, T., Kita, K., Donev, I. S., Nakamura, T., Matsumoto, K., Shimizu, E., Nishioka, Y., et al. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.05.023 · Cited by 68
Dynamic contrast‐enhanced‐MRI of tumor hypoxia
Egeland, T. A. M., Gulliksrud, K., Gaustad, J., Mathiesen, B. S., & Rofstad, E. K. (2011) · Magnetic Resonance in Medicine · doi:10.1002/mrm.23014 · Cited by 65
RhoB: Team Oncogene or Team Tumor Suppressor?
Ju, J. A., & Gilkes, D. M. (2018) · Genes · doi:10.3390/genes9020067 · Cited by 65
The Role of Oxygen in Avascular Tumor Growth
Grimes, D. R., Kannan, P., McIntyre, A., Kavanagh, A. P., Siddiky, A., Wigfield, S., Harris, A. L., & Partridge, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153692 · Cited by 67
Schoustra, S. M., Piras, D., Huijink, R., Root, T. J. P. M. O. '., Alink, L., Kobold, W. M. F., Steenbergen, W., & Manohar, S. (2019) · Journal of Biomedical Optics · doi:10.1117/1.jbo.24.12.121909 · Cited by 65
Biomedical application of manganese dioxide nanomaterials
Chen, Y., Cong, H., Shen, Y., et al. (2020) · Nanotechnology · doi:10.1088/1361-6528/ab6fe1 · Cited by 65
Ashokkumar, P., Adarsh, N., & Klymchenko, A. S. (2020) · Small · doi:10.1002/smll.202002494 · Cited by 64
Monocytic delivery of therapeutic oxygen bubbles for dual-modality treatment of tumor hypoxia
Huang, W., Shen, M., Chen, H., Lin, S., Chiang, W., Wu, P.-H., Chang, C., Chiang, C., & Chiu, H. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.09.016 · Cited by 64
Ding, G., Huang, G., Liu, H., Liang, H., Ni, Y., Ding, Z., Ni, G.-Y., & Hua, H.-W. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1795-3 · Cited by 64
Improving the Radiosensitivity of Radioresistant and Hypoxic Glioblastoma
Sheehan, J. P., Shaffrey, M. E., Gupta, B., Larner, J. M., Rich, J. N., & Park, D. M. (2010) · Future Oncology · doi:10.2217/fon.10.123 · Cited by 66
Tempol Protects against Oxidative Damage and Delays Epithelial Tumor Onset in Fanconi Anemia Mice
Zhang, Q., Eaton, L., Snyder, E. R., Houghtaling, S. R., Mitchell, J. B., Finegold, M. J., Waes, C. V., & Grompe, M. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5186 · Cited by 64
Liu, T., Karlsen, M., Karlberg, A. M., & Redalen, K. R. (2020) · EJNMMI Research · doi:10.1186/s13550-020-00621-5 · Cited by 65
Catalytic nanographene oxide with hemin for enhanced photodynamic therapy
Sahu, A., Min, K., Jeon, J., Yang, H. S., & Tae, G. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.07.023 · Cited by 64
Cancer-Related Anemia: Biological Findings, Clinical Implications and Impact on Quality of Life
Blohmer, J., Dunst, J., Harrison, L. B., Johnston, P., Khayat, D., Ludwig, H., O’Brien, M., Belle, S. V., & Vaupel, P. W. (2005) · Oncology · doi:10.1159/000083129 · Cited by 64
Self-citationAzuma, M., Shi, M. M., Danenberg, K. D., Gardner, H., Barrett, C. J., Jacques, C. J., Sherod, A., Iqbal, S., El-Khoueiry, A. B., Yang, D., et al. (2007) · Pharmacogenomics · doi:10.2217/14622416.8.12.1705 · Cited by 67
Ma, J., Zhang, Q. H., Chen, S., Fang, B., Yang, Q., Chen, C., Miele, L., Sarkar, F. H., Xia, J., & Wang, Z. P. (2013) · PLoS ONE · doi:10.1371/journal.pone.0069485 · Cited by 63
RetractedHypoxia: syndicating triple negative breast cancer against various therapeutic regimens
Srivastava, N., Usmani, S. S., Subbarayan, R., Saini, R., & Pandey, P. K. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1199105 · Cited by 69
Itani, W., Geara, F. B., Haykal, J., et al. (2007) · Radiation Oncology · doi:10.1186/1748-717x-2-1 · Cited by 63
Prognostic Potential Of The Pretherapeutic Tumor Oxygenation Status
Vaupel, P. W. (2008) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-85998-9_36 · Cited by 63
Self-citationThe impact of anaemia on outcome in cancer
Clarke, H., & Pallister, C. J. (2005) · Clinical & Laboratory Haematology · doi:10.1111/j.1365-2257.2004.00664.x · Cited by 64
Iakovlev, V. V., Pintilie, M., Morrison, A. J., Fyles, A., Hill, R. P., & Hedley, D. W. (2007) · Laboratory Investigation · doi:10.1038/labinvest.3700680 · Cited by 63
Tumour Hypoxia: Impact on Biology, Prognosis and Treatment of Solid Malignant Tumours
Weinmann, M., Belka, C., & Plaßwilm, L. (2004) · Oncology Research and Treatment · doi:10.1159/000075611 · Cited by 64
Recent advances in salivary cancer diagnostics enabled by biosensors and bioelectronics
Mishra, S., Saadat-Moghaddam, D., Kwon, O., Lee, Y.-K., Choi, W., Kim, J., & Yeo, W. (2016) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2016.02.040 · Cited by 68
Mathew, A. S., DeRosa, C. A., Demas, J. N., & Fraser, C. L. (2016) · Analytical Methods · doi:10.1039/c5ay02959g · Cited by 63
Longitudinal PET imaging of tumor hypoxia during the course of radiotherapy
Stieb, S., Eleftheriou, A., Warnock, G., et al. (2018) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-018-4116-y · Cited by 63
Role of Rac1 and Cdc42 in hypoxia induced p53 and von Hippel‐Lindau suppression and HIF1α activation
Xue, Y., Bi, F., Zhang, X., Zhang, S., Pan, Y., Liu, N., Shi, Y., Yao, X., Zheng, Y., & Fan, D. (2006) · International Journal of Cancer · doi:10.1002/ijc.21763 · Cited by 63
Metadata
- Authors
- Hockel, M., & Vaupel, P.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Vaupel, P.
- ORCID
- Vaupel, P.
- Venue
- JNCI Journal of the National Cancer Institute
- Publisher
- Oxford University Press (OUP)
- Published
- 2001-02-21
- Volume
- 93
- Issue
- 4
- Pages
- 266-276
- ISSN
- 0027-8874 (ISSN-L)
- 1460-2105
- OpenAlex
- W2125257427
- Semantic Scholar
- 6c70b98add72efaae8670b5183983be403de59ae
- Cited by
- 2,662
- References
- 159
- Citations by year
- 2026: 46 · 2025: 65 · 2024: 93 · 2023: 134 · 2022: 110 · 2021: 139 · 2020: 149 · 2019: 120 · 2018: 110 · 2017: 148 · 2016: 143 · 2015: 123 · 2014: 114 · 2013: 104 · 2012: 114
- FWCI
- 5.27
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JNCI Journal of the National Cancer Institute (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Keywords
- tumor hypoxia, tissue hypoxia, solid tumors, tumor microcirculation, oxygen partial pressure, tumor progression, treatment resistance, tumor physiology, oxygen diffusion
- MeSH terms
- Animals, Humans, Neoplasms, Oxygen, Predictive Value of Tests, Prognosis, Risk Factors, Cell Hypoxia, Disease Progression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review